THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 45,128,000 Value ($000) $42,800 Avg Close — Range —
Q1 2021
Shares 57,128,000 Value ($000) $58,386 Avg Close — Range —
Q4 2020
Shares 60,128,000 Value ($000) $56,891 Avg Close — Range —
Q3 2020
Shares 60,128,000 Value ($000) $53,448 Avg Close — Range —
Q2 2020
Shares 74,128,000 Value ($000) $72,085 Avg Close — Range —
Q1 2020
Shares 63,878,000 Value ($000) $63,270 Avg Close — Range —
Q4 2019
Shares 59,938,000 Value ($000) $62,897 Avg Close — Range —
Q3 2019
Shares 54,938,000 Value ($000) $50,969 Avg Close — Range —
Q2 2019
Shares 53,438,000 Value ($000) $46,427 Avg Close — Range —
Q1 2019
Shares 29,438,000 Value ($000) $28,653 Avg Close — Range —
Q4 2018
Shares 27,438,000 Value ($000) $28,214 Avg Close — Range —
Q3 2018
Shares 25,910,000 Value ($000) $30,698 Avg Close — Range —
Q2 2018
Shares 25,910,000 Value ($000) $25,565 Avg Close — Range —
Q1 2018
Shares 20,910,000 Value ($000) $21,264 Avg Close — Range —
Q4 2017
Shares 25,910,000 Value ($000) $28,415 Avg Close — Range —
Q3 2017
Shares 31,910,000 Value ($000) $39,150 Avg Close — Range —
Q2 2017
Shares 18,750,000 Value ($000) $25,363 Avg Close — Range —
Q1 2017
Shares 16,750,000 Value ($000) $21,257 Avg Close — Range —
Q4 2016
Shares 12,500,000 Value ($000) $14,393 Avg Close — Range —